Key facts
- It has raised $6.1M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Centech Accelerator, 3CC | Third Culture Capital, C100, Campus des technologies de la santé, INOVAIT — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for ViTAA
- ·The full record, as it builds
Funding rounds
No funding rounds for ViTAA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ViTAA
Developer of medical assessment devices designed for personalized medicine for the improved management of patients. The company's platform facilitates cloud-based software, with integrated artificial intelligence, that will significantly improve how patients with aortic aneurysms will be managed and treated, enabling physicians and doctors to treat the right patient at the right time with the right technique.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2019
- Employees
- 31
- Website
- vitaamedical.com/
- Ownership
- Privately Held (backing)
ViTAA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ViTAA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ViTAA in its N-PORT filings yet. We sweep new filings monthly.